Pune, Maharashtra -- (SBWIRE) -- 05/24/2019 -- According to a recent study by Fact.MR, the global breast cancer diagnostics market is projected to register a moderate CAGR of 4.7% during the forecast period 2017 to 2022. The report estimates the market to surpass US$ 2,000 Mn in revenues by 2022-end.

In diagnostic platforms of breast cancer, a number of technological advancements have led towards a robust transformation of the global breast cancer diagnostics market. The emergence of hybrid diagnostics instruments with the provision of an enhanced accuracy have been witnessed in the market. Advancements such as these have been fuelling growth of the global market for breast cancer diagnostics. Surging cases of breast cancer, coupled with growing older women population are anticipated to create potential growth opportunities for breast cancer diagnostics market across the globe. However, lack of skilled as well as trained personnel is expected to inhibit the demand for breast cancer diagnostics during the forecast period.

Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=55 

The most common type of cancer for women across the globe currently is breast cancer. The number of breast cancer cases is expected to witness a rise, leading towards the requirement for efficient and early breast cancer detection. An established method, mammography, adopted in many countries, has recently been observed to provide inconclusive test results. Personalized and risk-adapted therapy are expected to resolve these difficulties. Tomosythesis, which has emerged as a new imaging technology, promises to overcome the challenges incurred in mammography.

8 Estimations for the Global Breast Cancer Diagnostics Market

By test type, BRCA will remain dominant in the global breast cancer diagnostics market.
CA test for diagnostics of breast cancer is expected to register the highest CAGR through 2022 in the market, followed by ER & PR. Revenue from ER & PR, and CA tests will continue to be low throughout the forecast period.
HER 2 test is expected to remain the second largest segment among test type, in the market. However, EGFR mutation test is estimated to account for low revenues in the global market for breast cancer diagnostics.
North America will continue to be the largest market for breast cancer diagnostics. Revenues from breast cancer diagnostics market in North America is estimated to surpass US$ 800 Mn by 2022-end.
Europe will remain the second most lucrative region for the breast cancer diagnostics market. However, markets in Japan, and Middle East & Africa (MEA) are anticipated to witness a sluggish expansion throughout the forecast period.
Hospital-associated labs will remain sought-after among end-users for breast cancer diagnostics around the world. Revenues from breast cancer diagnostics will remain largest in hospital-associated labs, followed by the independent diagnostic laboratories.
Cancer research institutes are anticipated to exhibit the highest CAGR during the forecast period. Between 2017 and 2022, cancer research institutes are estimated to create absolute $ opportunity of US$ 107.3 Mn.
Key market players mentioned in Fact.MR's report include Siemens AG, Myriad Genetics, Inc., Roche Holding AG, Illumina, Inc., Epigenomics AG, Abbott Laboratories, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories, Inc., Biocept, Inc., AstraZeneca plc, and Quest Diagnostics Incorporated.
Browse Full Report @ https://www.factmr.com/report/55/breast-cancer-diagnostics-market 

To deliver a seamless understanding of the Breast Cancer Diagnostics  market, the report is divided into 18 sophisticated chapters whose snapshots are provided below.

Chapter 1 – Executive Summary
The report commences with the chapter of the executive summary which delivers brief yet affluent information of the Breast Cancer Diagnostics  market. The chapter includes discussion on the market overview, market analysis and market recommendations regarding the Breast Cancer Diagnostics  market derived based on Fact.MR's proprietary wheel of fortune.

Chapter 2 – Market Introduction
In the market introduction chapter, the Breast Cancer Diagnostics  market is introduced along with the
market segmentation in the form of market taxonomy. The chapter also introduces the Breast Cancer Diagnostics  in the market definition section.

Chapter 3 - Breast Cancer Diagnostics  Market Background
In this chapter, macroeconomic factors, market dynamics, a complete value chain and pricing
analysis with regard to Breast Cancer Diagnostics  market is elaborately discussed. Discussion on the
market drivers, restraints, trends and opportunities and their impact on the market forecast is also
covered in this chapter.

You can Buy This Report from Here @ https://www.factmr.com/checkout/55/S 

Chapter 4 - Global Breast Cancer Diagnostics  Market Analysis 2013–2017 and Forecast 2018–2026
This chapter provides the Breast Cancer Diagnostics  market size in terms of market volume and value
during the forecast period. Market analysis based on absolute $ opportunity and y-o-y growth of the Breast Cancer Diagnostics  market is also covered in this chapter.

Chapter 5 - Global Breast Cancer Diagnostics  Market Analysis 2013–2017 and Forecast 2018–2026,

By System Type Based on system types in the Breast Cancer Diagnostics  market, the chapter elaborates market size of individual systems and analysis by system types and summary of this section is covered in the chapter.

Chapter 6 - Global Breast Cancer Diagnostics  Market Analysis 2013–2017 and Forecast 2018–2026, By Application

Based on applications, Market size of individual applications, their market attractiveness analysis and summary are also covered.

Chapter 7 - Global Breast Cancer Diagnostics  Market Analysis 2013–2017 and Forecast 2018–2026, By End User

This chapter elaborates the segmentation of the Breast Cancer Diagnostics  market based on end users
including independent end users, Market attractive analysis by end users is also discussed to fathom relative lucrativeness of different end users of the Breast Cancer Diagnostics  market.

Chapter 8 - Global Breast Cancer Diagnostics  Market Analysis 2013–2017 and Forecast 2018–2026, By Region

With the geographical perspective, the Breast Cancer Diagnostics  market is analyzed on a total of seven regions including North America, Latin America, Europe, South East Asia & Pacific, Middle East & Africa, China and Japan. Historical data and prevailing trends in the Breast Cancer Diagnostics  market and their influence on the global market performance is discussed in this chapter.

And Continue....